Literature DB >> 20049627

Biochemical characterization of soluble nucleotide pyrophosphatase/phosphodiesterase activity in rat serum.

Danijela Laketa1, Ivana Bjelobaba, Jasmina Savic, Irena Lavrnja, Mirjana Stojiljkovic, Ljubisav Rakic, Nadezda Nedeljkovic.   

Abstract

Biochemical properties of nucleotide pyrophosphatase/phosphodiesterase (NPP) in rat serum have been described by assessing its nucleotide phosphodiesterase activity, using p-nitrophenyl-5'-thymidine monophosphate (p-Nph-5'-TMP) as a substrate. It was demonstrated that NPP activity shares some typical characteristics described for other soluble NPP, such as divalent cation dependence, strong alkaline pH optimum (pH 10.5), inhibition by glycosaminoglycans, and K (m) for p-Nph-5'-TMP hydrolysis of 61.8 +/- 5.2 microM. In order to characterize the relation between phosphodiesterase and pyrophosphatase activities of NPP, we have analyzed the effects of different natural nucleotides and nucleotide analogs. ATP, ADP, and AMP competitively inhibited p-Nph-5'-TMP hydrolysis with K (i) values ranging 13-43 microM. Nucleotide analogs, alpha,beta-metATP, BzATP, 2-MeSATP, and dialATP behaved as competitive inhibitors, whereas alpha,beta-metADP induced mixed inhibition, with K (i) ranging from 2 to 20 microM. Chromatographic analysis revealed that alpha,beta-metATP, BzATP, and 2-MeSATP were catalytically degraded in the serum, whereas dialATP and alpha,beta-metADP resisted hydrolysis, implying that the former act as substrates and the latter as true competitive inhibitors of serum NPP activity. Since NPP activity is involved in generation, breakdown, and recycling of extracellular adenine nucleotides in the vascular compartment, the results suggest that both hydrolyzable and non-hydrolyzable nucleotide analogs could alter the amplitude and direction of ATP actions and could have potential therapeutic application.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20049627     DOI: 10.1007/s11010-009-0373-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Degradation of extracellular nucleotides and their analogs in HeLa and HUVEC cell cultures.

Authors:  Edyta Gendaszewska-Darmach; Maria Maszewska; Małgorzata Zakłos; Maria Koziołkiewicz
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma.

Authors:  B Grobben; K Anciaux; D Roymans; C Stefan; M Bollen; E L Esmans; H Slegers
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

Review 4.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

5.  Determination of selected pyrimidines, purines and their metabolites in serum and urine by reversed-phase ion-pair chromatography.

Authors:  W Voelter; K Zech; P Arnold; G Ludwig
Journal:  J Chromatogr       Date:  1980-10-31

6.  A soluble PC-1 circulates in human plasma: relationship with insulin resistance and associated abnormalities.

Authors:  L Frittitta; S Camastra; R Baratta; B V Costanzo; M D'Adamo; S Graci; D Spampinato; B A Maddux; R Vigneri; E Ferrannini; V Trischitta
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

7.  Structure Activity Relationships for Derivatives of Adenosine-5'-Triphosphate as Agonists at P(2) Purinoceptors: Heterogeneity Within P(2X) and P(2Y) Subtypes.

Authors:  Geoffrey Burnstock; Bilha Fischer; Charles H V Hoyle; Michel Maillard; Airat U Ziganshin; Antonia L Brizzolara; Amy von Isakovics; José L Boyer; T Kendall Harden; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  2004-10-05       Impact factor: 4.360

Review 8.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

9.  Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase.

Authors:  M Picher; J Sévigny; P D'Orléans-Juste; A R Beaudoin
Journal:  Biochem Pharmacol       Date:  1996-06-14       Impact factor: 5.858

10.  Ectonucleotidase activities are altered in serum and platelets of L-NAME-treated rats.

Authors:  Cristina Ribas Fürstenau; Danielle da Silva Trentin; Agnes Nogueira Gossenheimer; Denise Barbosa Ramos; Emerson André Casali; Maria Luiza Morais Barreto-Chaves; João José Freitas Sarkis
Journal:  Blood Cells Mol Dis       Date:  2008-06-17       Impact factor: 3.039

View more
  5 in total

Review 1.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

Review 2.  Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.

Authors:  Sang-Yong Lee; Christa E Müller
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

3.  Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.

Authors:  Sang-Yong Lee; Vigneshwaran Namasivayam; Nader M Boshta; Arianna Perotti; Salahuddin Mirza; Silvia Bua; Claudiu T Supuran; Christa E Müller
Journal:  RSC Med Chem       Date:  2021-06-16

4.  Brain Injury Alters Ectonucleotidase Activities and Adenine Nucleotide Levels in Rat Serum.

Authors:  Danijela Laketa; Jasmina Savić; Ivana Bjelobaba; Irena Lavrnja; Vesna Vasić; Mirjana Stojiljković; Nadežda Nedeljković
Journal:  J Med Biochem       Date:  2015-03-03       Impact factor: 3.402

5.  Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors.

Authors:  Sang-Yong Lee; Soumya Sarkar; Sanjay Bhattarai; Vigneshwaran Namasivayam; Steven De Jonghe; Holger Stephan; Piet Herdewijn; Ali El-Tayeb; Christa E Müller
Journal:  Front Pharmacol       Date:  2017-02-15       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.